Newly diagnosed epilepsy: Cognitive outcome at 5 years

Epilepsy and Behavior

Volumn 18, Issue 4, 2010, Pages 397-403

  Taylor, Joanne ^a   Baker, Gus A ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Cognition; Epilepsy; Neuropsychological outcome; Newly diagnosed

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PREGABALIN; TOPIRAMATE; VALPROIC ACID;

ADULT; AGED; ANTICONVULSANT THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EPILEPSY; FEMALE; FOLLOW UP; HUMAN; MALE; MEMORY; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; COGNITION DISORDERS; EPILEPSY; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; YOUNG ADULT;

EID: 77955570224     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2010.05.007     Document Type: Article

References (55)

1. Kwan P., Brodie M.J. Neuropsychological effects of epilepsy and antiepileptic drugs. Lancet 2001, 357:216-222.
2. Meador K.J. Cognitive outcomes and predictive factors in epilepsy. Neurology 2002, 58(Suppl. 5):S21-S26.
3. Motamedi G., Meador K.J. Epilepsy and cognition. Epilepsy Behav 2003, 4:S25-S38.
4. Aldenkamp A.P., Bodde N. Behaviour, cognition and epilepsy. Acta Neurol Scand 2005, 112:19-25.
5. Marques C.M., Caboclo L.O., da Silva T.I., et al. Cognitive decline in temporal lobe epilepsy due to unilateral hippocampal sclerosis. Epilepsy Behav 2007, 10:477-485.
6. Jokeit H., Ebner A. Long term effects of refractory temporal lobe epilepsy on cognitive abilities: a cross-sectional study. J Neurol Neurosurg Psychiatry 1999, 67:44-50.
7. Jokeit H., Luerding R., Ebner A. Cognitive impairment in temporal-lobe epilepsy. Lancet 2000, 355:1018-1019.
8. Hermann B.P., Seidenberg M., Bell B., et al. The neurodevelopmental impact of childhood-onset temporal lobe epilepsy on brain structure and function. Epilepsia 2002, 43:1062-1071.
9. Oyegbile T.O., Dow C., Jones J., et al. The nature and course of neuropsychological morbidity in chronic temporal lobe epilepsy. Neurology 2004, 62:1736-1742.
10. Kent G.P., Schefft B.K., Howe S.R., Szaflarski J.P., Yeh H.-S., Privitera M.D. The effects of duration of intractable epilepsy on memory function. Epilepsy Behav 2006, 9:469-477.
11. Helmstaedter C., Elger C.E. The phantom of progressive dementia in epilepsy. Lancet 1999, 18:2133-2134.
12. Helmstaedter C., Elger C.E. Chronic temporal lobe epilepsy: a neurodevelopmental or progressively dementing disease?. Brain 2009, 132:2822-2830.
13. Dodrill C.B. Neuropsychological effects of seizures. Epilepsy Behav 2004, 5:S21-S24.
14. Seidenberg M., Pulsipher D.T., Hermann B. Cognitive progression in epilepsy. Neuropsychol Rev 2007, 17:445-454.
15. Arieff A.J., Yacorzynski G.K. Deterioration of patients with organic epilepsy. J Nerv Ment Dis 1942, 96:49-55.
16. Holmes M.D., Dodrill C.B., Wilkus R.J., Ojemann L.M., Ojemann G.A. Is partial epilepsy progressive? Ten-year follow-up of EEG and neuropsychological changes in adults with partial seizures. Epilepsia 1998, 39:1189-1193.
17. Helmstaedter C., Kurthen M., Lux S., et al. Temporal lobe epilepsy: longitudinal clinical, neuropsychological and psychosocial follow-up of surgically and conservatively managed patients. Nervenarzt 2000, 71:629-642.
18. Helmstaedter C., Kurthen M., Lux S., Reuber M., Elger C.E. Chronic epilepsy and cognition: a longitudinal study in temporal lobe epilepsy. Ann Neurol 2003, 54:425-432.
19. Andersson-Roswall L., Engman E., Samuelsson H., Sjöberg-Larsson C., Malmgren K. Verbal memory decline and adverse effects on cognition in adult patients wih pharmacoresistant partial epilepsy: a longitudinal controlled study of 36 patients. Epilepsy Behav 2004, 5:677-686.
20. Thompson P.J., Duncan J.S. Cognitive decline in severe intractable epilepsy. Epilepsia 2005, 46:1780-1787.
21. Hermann B.P., Seidenberg M., Dow C., et al. Cognitive prognosis in chronic temporal lobe epilepsy. Ann Neurol 2006, 60:80-87.
22. Piazzini A., Turner K., Chifari R., Morabito A., Canger R., Canevini M.P. Attention and psychomotor speed decline in patients with temporal lobe epilepsy: a longitudinal study. Epilepsy Res 2006, 72:89-96.
23. Seidenberg M., O'Leary D.S., Berent S., Boll T. Changes in seizure frequency and test-retest scores on the Wechsler Adult Intelligence Scale. Epilepsia 1981, 22:75-83.
24. Kalska H. Cognitive changes in epilepsy: a ten year follow-up. Commentationes Scientiarum Socialium. Helsinki: Societas Scientiarum Fennica 1991.
25. Dodrill C.B., Wilensky A.J. Neuropsychological abilities before and after 5years of stable antiepileptic drug therapy. Epilepsia 1992, 32:327-334.
26. Selwa L.M., Berent S., Giordani B., Henry T.R., Buchtel H.A., Ross D.A. Serial cognitive testing in temporal lobe epilepsy: longitudinal changes with medical and surgical therapies. Epilepsia 1994, 35:743-749.
27. Aikia M., Kalviainen R., Riekkinen P. Five-year follow-up of cognitive performance of adult patients with well-controlled partial epilepsy. Epilepsia 1999, 40:100-101.
28. Aikia M., Salmenpera T., Partanen K., Kalviainen R. Verbal memory in newly diagnosed patients and patients with chronic left temporal lobe epilepsy. Epilepsy Behav 2001, 2:20-27.
29. Bjørnæs H., Stabell K., Henriksen O., Løyning Y. The effects of refractory epilepsy on intellectual functioning in children and adults: a longitudinal study. Seizure 2001, 10:250-259.
30. Dodrill C.B. Progressive cognitive decline in adolescents and adults with epilepsy. Prog Brain Res 2002, 135:399-407.
31. Griffith H.R., Martin R.C., Bambara J.K., Faught E., Vogtle L.K., Marson D.C. Cognitive functioning over 3years in community dwelling older adults with chronic partial epilepsy. Epilepsy Res 2007, 74:91-96.
32. Taylor J., Kolamunnage-Dona R., Marson A.G., Smith P.E., Aldenkamp A.P., Baker G.A. Patients with epilepsy: Cognitively compromised before the start of antiepileptic drug treatment?. Epilepsia 2010, 51:48-56.
33. Marson A.G., Al-Kharusi A.M., Alwaidh M., et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007, 24:1000-1015.
34. Marson A.G., Al-Kharusi A.M., Alwaidh M., et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 2007, 24:1016-1026.
35. Alpherts W.C.J. Computers as a technique for neuropsychological assessment in epilepsy. Education and epilepsy 1987, 101-109. Swets & Zeitlinger, Lisse/Berwyn. A.P. Aldenkamp, W.C.J. Alpherts, H. Meinardi, G. Stores (Eds.).
36. Cochrane H.C., Marson A.G., Baker G.A., Chadwick D.W. Neuropsychological outcomes in randomised controlled trials of antiepileptic drugs: a systematic review of methodology and reporting standards. Epilepsia 1998, 39:1088-1097.
37. Baker G.A., Marson A.G. Cognitive and behavioural assessments in clinical trials: what type of measure?. Epilepsy Res 2001, 45:163-167.
38. Beglinger L.J., Gaydos B., Tangphao-Daniels O., et al. Practice effects and the use of alternate forms in serial neuropsychological testing. Arch Clin Neuropsychol 2005, 20:517-529.
39. Trenerry M.R., Crosson B., DeBoe J., Leber W.R. The Stroop Neuropsychological Screening Test 1989, Psychological Assessment Resources, Odessa, FL.
40. Aldenkamp A.P., Baker G.A., Mulder O.G., et al. A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures. Epilepsia 2000, 41:1167-1178.
41. Gomer B., Wagner K., Frings L., et al. The influence of antiepileptic drugs on cognition: a comparison of levetiracetam with topiramate. Epilepsy Behav 2007, 10:486-494.
42. Frerichs R.J., Tuokko H.A. A comparison of methods for measuring cognitive change in older adults. Arch Clin Neuropsychol 2005, 20:321-333.
43. Hermann B., Seidenberg M., Jones J. The neurobehavioural comorbidities of epilepsy: can a natural history be developed?. Lancet Neurol 2008, 7:151-160.
44. Blum D., Meador K., Biton V., et al. Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy. Neurology 2006, 67:400-406.
45. Fritz N., Glogau S., Hoffmann J., Rademacher M., Elger C.E., Helmstaedter C. Efficacy and cognitive side effects of tigabine and topiramate in patients with epilepsy. Epilepsy Behav 2005, 6:373-381.
46. Martin R., Kuzniecky R., Ho S., et al. Cognitive effects of topiramate, gabapentin and lamotrigine in healthy young adults. Neurology 1999, 52:321-327.
47. Meador K., Loring D.W., Hulihan J.F., Kamin M., Karim R. Differential cognitive and behavioural effects of topiramate and valproate. Neurology 2003, 60:1483-1488.
48. Meador K., Loring D.W., Vahle V.J., et al. Cognitive and behavioural effects of lamotrigine and topiramate in healthy volunteers. Neurology 2005, 64:2108-2114.
49. Salinsky M.C., Storzbach D., Spencer D.C., Oken B.S., Landry T., Dodrill C.B. Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers. Neurology 2005, 64:792-798.
50. Reitan R.M., Wolfson D. Emotional disturbances and their interaction with neuropsychological deficits. Neuropsychol Rev 1997, 7:3-19.
51. Douglas K.M., Porter R.J. Longitudinal assessment of neuropsychological function in major depression. Aust NZ J Psychiatry 2009, 43:1105-1117.
52. Paradiso S., Hermann B.P., Blumer D., Davies K., Robinson R.G. Impact of depressed mood on neuropsychological status in temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 2001, 70:180-185.
53. Coughlan A.K., Hallows S.E. The Adult Memory and Information Processing Battery (AMIPB) 1985, A.K. Coughlan, Leeds.
54. Elger C.E., Helmstaedter C., Kurthen M. Chronic epilepsy and cognition. Lancet Neurol 2004, 3:663-672.
55. Hirsch E., Schmitz B., Carreño M. Epilepsy, antiepileptic drugs and cognition. Acta Neurol Scand 2003, 108:23-32.